NO- and H2S- releasing nanomaterials: A crosstalk signaling pathway in cancer DOI
Roberta Albino dos Reis,

Ishani Sarkar,

Maiara Gonçalves Rodrigues

et al.

Nitric Oxide, Journal Year: 2024, Volume and Issue: 151, P. 17 - 30

Published: Aug. 23, 2024

Language: Английский

Harnessing stimuli-responsive NO nanomaterials for advanced multi-disease therapy DOI
Junjie Zhang, Haiyang Guo, Longguang Tang

et al.

Coordination Chemistry Reviews, Journal Year: 2025, Volume and Issue: 533, P. 216540 - 216540

Published: Feb. 27, 2025

Language: Английский

Citations

0

sEmerging glucose oxidase-delivering nanomedicines for enhanced tumor therapy DOI

Kai‐Yue Song,

Ming Jiang, Bailong Tao

et al.

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: 381, P. 113580 - 113580

Published: Feb. 28, 2025

Language: Английский

Citations

0

Functionalized ZIF-8 as a versatile platform for drug delivery and cancer therapy: strategies, challenges and prospects DOI

Wenyue Gao,

Xinping Han,

Ling Li

et al.

Journal of Materials Chemistry B, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

This review discusses the functionalization strategies of ZIF-8 and challenges future developments in ZIF-8-based platforms for drug delivery cancer therapy.

Language: Английский

Citations

0

Current status of controlled onco-therapies based on metal organic frameworks DOI Creative Commons

Yixuan Yang,

Xiaofeng Dai

RSC Advances, Journal Year: 2024, Volume and Issue: 14(18), P. 12817 - 12828

Published: Jan. 1, 2024

Most MOFs for controllable cancer treatment act as drug delivery vehicle and/or anti-cancer agent. Molecules with roles such chemotherapies, gases, peptides or nucleic acids can be loaded into that decompose in cells the TME to release its cargoes.

Language: Английский

Citations

3

Iron‐MOFs for Biomedical Applications DOI Creative Commons
Zhihao Yu, Mathilde Lepoitevin, Christian Serre

et al.

Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 10, 2024

Over the past two decades, iron-based metal-organic frameworks (Fe-MOFs) have attracted significant research interest in biomedicine due to their low toxicity, tunable degradability, substantial drug loading capacity, versatile structures, and multimodal functionalities. Despite great potential, transition of Fe-MOFs-based composites from laboratory clinical products remains challenging. This review evaluates key properties that distinguish Fe-MOFs other MOFs highlights recent advances synthesis routes, surface engineering, shaping technologies. In particular, it focuses on applications biosensing, antimicrobial, anticancer therapies. addition, emphasizes need develop scalable, environmentally friendly, cost-effective production methods for additional meet specific requirements various biomedical applications. ability combine therapies, hurdles still remain, including a deeper understanding therapeutic mechanisms potential risks resistance overdose. Systematically addressing these challenges could significantly enhance prospects potentially facilitate integration into mainstream practice.

Language: Английский

Citations

3

Advances in multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer starvation therapy DOI
Jin Cai, Yan Xu, Fei Liao

et al.

Expert Reviews in Molecular Medicine, Journal Year: 2024, Volume and Issue: 26

Published: Jan. 1, 2024

Cancer remains a significant threat to human health today. Even though starvation therapy and other treatment methods have recently advanced new level of rapid development in tumour treatment, their limited therapeutic effectiveness unexpected side effects prevent them from becoming the first option clinical treatment. With advancement nanotechnology, utilization nanomaterials therapeutics offers potential address shortcomings cancer Notably, multifunctional metal-organic framework (MOF) has been widely employed due customizable shape, adjustable diameter, high porosity, diverse compositions, large specific surface area, degree functionalization strong biocompatibility. This paper reviews current progress success MOF-based nanoplatforms for therapy, as well prospects barriers application MOF therapy.

Language: Английский

Citations

3

Multifunctional nanoplatform with near-infrared triggered nitric-oxide release for enhanced tumor ferroptosis DOI Creative Commons
Min Wang,

Zhuangli Zhang,

Qianqian Li

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Oct. 26, 2024

Language: Английский

Citations

3

Programmable Nanomodulators for Precision Therapy, Engineering Tumor Metabolism to Enhance Therapeutic Efficacy DOI
Siwei Liu, Zhijun Liu, Huajiang Lei

et al.

Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: 14(4)

Published: Nov. 12, 2024

Tumor metabolism is crucial in the continuous advancement and complex growth of cancer. The emerging field nanotechnology has made significant strides enhancing understanding metabolic intricacies inherent to tumors, offering potential avenues for their strategic manipulation achieve therapeutic goals. This comprehensive review delves into interplay between tumor various facets cancer, encompassing its origins, progression, formidable challenges posed by metastasis. Simultaneously, it underscores classification programmable nanomodulators transformative impact on cancer treatment, particularly when integrated with modalities such as chemotherapy, radiotherapy, immunotherapy. also encapsulates mechanisms which modulate metabolism, including delivery inhibitors, regulation oxidative stress, pH value modulation, nanoenzyme catalysis, nutrient deprivation, RNA interference technology, among others. Additionally, prospects clinical applications. Finally, innovative concept using reprogram pathways introduced, aiming transform cells back normal cells. profound that tailored can have metabolic, charting a path toward pioneering precision therapies

Language: Английский

Citations

2

Smart Magnetic Nanocarriers for Codelivery of Nitric Oxide and Doxorubicin for Enhanced Apoptosis in Cancer Cells DOI Creative Commons

Bijaideep Dutta,

Sandeep B. Shelar,

Ananya Nirmalraj

et al.

ACS Omega, Journal Year: 2023, Volume and Issue: 8(47), P. 44545 - 44557

Published: Nov. 15, 2023

Extremely short half-life therapeutic molecule nitric oxide (NO) plays significant roles in the functioning of various physiological and pathological processes human body, whereas doxorubicin hydrochloride (DOX) is a clinically important anticancer drug widely used cancer chemotherapy. Thus, intracellular delivery these molecules tremendously to achieve their full potential. Herein, we report novel approach for development highly water-dispersible magnetic nanocarriers codelivery NO DOX. Primarily, bifunctional nanoparticles enriched with carboxyl thiol groups were prepared by introducing cysteine onto surface citrate-functionalized Fe3O4 nanoparticles. DOX was electrostatically conjugated via moieties, group further nitrosated provide NO-releasing molecules. The developed nanocarrier exhibited good aqueous colloidal stability, protein resistance behavior, high encapsulation efficacy (65.5%) (85%), as well sustained release characteristics. Moreover, they showed superior cytotoxicity toward (A549 MCF-7) cells apoptosis induction over normal (WI26VA4) cells. Specifically, have having capability dual DOX, which holds great potential combinatorial treatment.

Language: Английский

Citations

5

NO- and H2S- releasing nanomaterials: A crosstalk signaling pathway in cancer DOI
Roberta Albino dos Reis,

Ishani Sarkar,

Maiara Gonçalves Rodrigues

et al.

Nitric Oxide, Journal Year: 2024, Volume and Issue: 151, P. 17 - 30

Published: Aug. 23, 2024

Language: Английский

Citations

1